Comparative Study of Chemical Sphincterotomy and Lateral Internal Sphincterotomy for Chronic Anal Fissure

Nitesh Kumar, Deepak Pankaj, Nitesh, Ashwini Kumar, M. Raj
{"title":"Comparative Study of Chemical Sphincterotomy and Lateral Internal Sphincterotomy for Chronic Anal Fissure","authors":"Nitesh Kumar, Deepak Pankaj, Nitesh, Ashwini Kumar, M. Raj","doi":"10.5958/2321-1024.2019.00025.4","DOIUrl":null,"url":null,"abstract":"Introduction \nFissure-in-ano is a very common problem which causes considerable morbidity and affects the patient's quality of life to a great extent. This warrants prompt treatment of the condition with appropriate methods. In this study, we assess and compare the efficacy and adverse effects of topical application of 2% Diltiazem gel with that of Lateral internal sphincterotomy. \nMethod \n100 patients with chronic fissure in ano were divided into Diltiazem gel and Lateral internal sphincterotomy groups and followed up at regular intervals for symptomatic relief and healing. \nResults \nFissure was completely healed in 42 (89.36%) out of 47 patients by 8 weeks in the Diltiazem group, 3 patients experienced mild headache, 2 local irritation, 13 patients were pain-free at the end of 4 weeks, 26 patients were 8 weeks and 3 patients by 14 weeks. 5 patients were not relieved of pain at the end of 14 weeks. Completely healed in 48 (100%) out of 48 patients by 4 weeks in the Lateral Internal Sphincterotomy group.21 patients experienced post-operative pain and incontinence for flatus in 1 patient. 32 patients were pain-free by 4 weeks and all the patients were free of pain by 8 weeks. \nConclusion \nThe current study shows results in favour of lateral internal sphincterotomy with a healing rate of 100% with a faster pain-relief and minimal complications if performed by the experienced surgeon. However topical 2% diltiazem gel is an effective agent can be safely prescribed for patients having contraindications for surgery. With a healing rate close to 90%, topical 2% Diltiazem therapy can be advised as the first line of treatment for the treatment of chronic anal fissure.","PeriodicalId":113416,"journal":{"name":"International journal of contemporary surgery","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of contemporary surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5958/2321-1024.2019.00025.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Fissure-in-ano is a very common problem which causes considerable morbidity and affects the patient's quality of life to a great extent. This warrants prompt treatment of the condition with appropriate methods. In this study, we assess and compare the efficacy and adverse effects of topical application of 2% Diltiazem gel with that of Lateral internal sphincterotomy. Method 100 patients with chronic fissure in ano were divided into Diltiazem gel and Lateral internal sphincterotomy groups and followed up at regular intervals for symptomatic relief and healing. Results Fissure was completely healed in 42 (89.36%) out of 47 patients by 8 weeks in the Diltiazem group, 3 patients experienced mild headache, 2 local irritation, 13 patients were pain-free at the end of 4 weeks, 26 patients were 8 weeks and 3 patients by 14 weeks. 5 patients were not relieved of pain at the end of 14 weeks. Completely healed in 48 (100%) out of 48 patients by 4 weeks in the Lateral Internal Sphincterotomy group.21 patients experienced post-operative pain and incontinence for flatus in 1 patient. 32 patients were pain-free by 4 weeks and all the patients were free of pain by 8 weeks. Conclusion The current study shows results in favour of lateral internal sphincterotomy with a healing rate of 100% with a faster pain-relief and minimal complications if performed by the experienced surgeon. However topical 2% diltiazem gel is an effective agent can be safely prescribed for patients having contraindications for surgery. With a healing rate close to 90%, topical 2% Diltiazem therapy can be advised as the first line of treatment for the treatment of chronic anal fissure.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
化学括约肌切开术与外侧内括约肌切开术治疗慢性肛裂的比较研究
骨裂是一种非常常见的疾病,其发病率很高,并在很大程度上影响患者的生活质量。这就需要用适当的方法及时治疗这种情况。在这项研究中,我们评估并比较了局部应用2%地尔硫卓凝胶与外侧内括约肌切开术的疗效和不良反应。方法将100例慢性肛裂患者分为地尔硫卓凝胶组和外侧内括约肌切开术组,定期随访观察症状缓解和愈合情况。结果地尔硫卓组47例患者8周时,42例(89.36%)裂隙完全愈合,3例出现轻度头痛,2例局部刺激,4周时无疼痛13例,8周时26例,14周时3例。5例患者14周后疼痛仍未缓解。外侧内括约肌切开术组48例患者在4周内完全愈合(100%)。21例患者出现术后疼痛和尿失禁1例。32例患者4周无疼痛,8周无疼痛。结论:目前的研究结果表明,如果由经验丰富的外科医生进行,外侧内括约肌切开术的治愈率为100%,疼痛缓解速度更快,并发症最少。然而,局部2%地尔硫卓凝胶是一种有效的药物,可以安全地用于有手术禁忌症的患者。慢性肛裂的治愈率接近90%,建议采用2%地尔硫卓局部治疗作为一线治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparative Study of Collagen Density, Fibroblast, and Neovascularization in Tracheal Defect Reconstruction with Primary Repair and External Oblique Muscle Aponeurosis Patch (A Novel Study with New Zealand Rabbit) Double Parathyroid Adenoma: Culprit Behind A Non- Functioning Kidney Role of Probiotics in Reducing GERD Effects of Immediate Post Operative Orthopaedic Rehabilitation in Lower Limb Open Reduction Internal Fixation’s Orthopaedic Surgeries to Reduce Fear Avoidance Behaviour and Early Ambulation To Study the Repair of Incisional Hernia by Preperitoneal Meshplasty
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1